Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The senescence-associated secretome of Hedgehog-deficient hepatocytes drives MASLD progression
Ji Hye Jun, … , Steven S. Pullen, Anna Mae Diehl
Ji Hye Jun, … , Steven S. Pullen, Anna Mae Diehl
Published August 27, 2024
Citation Information: J Clin Invest. 2024;134(19):e180310. https://doi.org/10.1172/JCI180310.
View: Text | PDF
Research Article Hepatology Metabolism

The senescence-associated secretome of Hedgehog-deficient hepatocytes drives MASLD progression

  • Text
  • PDF
Abstract

The burden of senescent hepatocytes correlates with the severity of metabolic dysfunction–associated steatotic liver disease (MASLD), but the mechanisms driving senescence and how it exacerbates MASLD are poorly understood. Hepatocytes experience lipotoxicity and become senescent when Smoothened (Smo) is deleted to disrupt Hedgehog signaling. We aimed to determine whether the secretomes of Smo-deficient hepatocytes perpetuate senescence to drive MASLD progression. RNA-Seq analysis of liver samples from human and murine cohorts with MASLD confirmed that hepatocyte populations in MASLD livers were depleted of Smo+ cells and enriched with senescent cells. When fed a choline-deficient, amino acid–restricted high-fat diet (CDA-HFD) to induce MASLD, Smo– mice had lower antioxidant markers and developed worse DNA damage, senescence, steatohepatitis, and fibrosis than did Smo+ mice. Sera and hepatocyte-conditioned medium from Smo– mice were depleted of thymidine phosphorylase (TP), a protein that maintains mitochondrial fitness. Treating Smo– hepatocytes with TP reduced senescence and lipotoxicity, whereas inhibiting TP in Smo+ hepatocytes had the opposite effect and exacerbated hepatocyte senescence, steatohepatitis, and fibrosis in CDA-HFD–fed mice. We conclude that inhibition of Hedgehog signaling in hepatocytes promoted MASLD by suppressing hepatocyte production of proteins that prevent lipotoxicity and senescence.

Authors

Ji Hye Jun, Kuo Du, Rajesh Kumar Dutta, Raquel Maeso-Diaz, Seh Hoon Oh, Liuyang Wang, Guannan Gao, Ana Ferreira, Jon Hill, Steven S. Pullen, Anna Mae Diehl

×

Figure 2

Hepatocyte Smo-KO secretome is depleted of factors that promote antioxidant defense.

Options: View larger image (or click on image) Download as PowerPoint
Hepatocyte Smo-KO secretome is depleted of factors that promote antioxid...
Heatmap from proteome profiler analysis in (A) serum of Smo-KO mice and (B) conditioned medium of oleic acid– and palmitic acid–treated Smo-KO primary hepatocytes (n = 3 per group). TP protein expression by (C) immunoblotting (n = 3 per group), (D and E) immunohistochemistry of mouse total liver (n = 5 controls, n = 4 Smo-KO), and (F) ELISA using serum from mice (n = 9 control mice; n = 10 Smo-KO mice). (D) Original magnification, ×10 (low magnification), ×40 (high magnification), and ×100 (insets). (G) Representative images of staining for TP, Nrf2, and HO1 and (H) quantification of the positively stained areas in cells from patients with MASLD versus healthy control cells (n = 3 individuals per group). (G) Original magnification for TP images, ×10 (low magnification), ×40 (high magnification), and ×100 (insets). Original magnification for Nrf2 images, ×20 (low magnification), ×40 (high magnification), and ×100 (insets). Original magnification for HO1 images, ×10 (low magnification), ×40 (high magnification), and ×100 (insets). Data are graphed as the mean ± SEM. *P < 0.05, by 1-way ANOVA.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts